mend therapeutics, inc.

p.o. box 48
shrewsbury, massachusetts 01545

NYS Entity Status
ACTIVE

NYS Filing Date
OCTOBER 24, 2013

NYS DOS ID#
4477662

County
NEW YORK

Jurisdiction
MASSACHUSETTS

Registered Agent
NONE

NYS Entity Type
FOREIGN NOT-FOR-PROFIT CORPORATION

Name History
2013 - MEND THERAPEUTICS, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • News Analysis: Tough Task for Next Uber Leader: Mending Fences With Drivers
    By KEVIN ROOSE - Thursday Jun 22, 2017

    With Travis Kalanick out as Uber’s chief executive, the company has a chance to improve its treatment of drivers. An option for tipping drivers is a start.

    Source: NYT > Home Page
  • Neighborhood Joint: Tailoring in a Basement? It Suits Him
    By SYLVIE BIGAR - Wednesday Jun 28, 2017

    For 36 years, Bilal Egilmez, who learned his trade in Turkey, has altered and mended clothing at Genius Tailor, his Upper East Side shop.

    Source: NYT > Home Page
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York
  • Insurers Battle Families Over Costly Drug for Fatal Disease
    By KATIE THOMAS - Thursday Jun 22, 2017

    The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.

    Source: NYT > Home Page
mend therapeutics inc shrewsbury ny